» Articles » PMID: 2231266

In Vivo and in Vitro Evidence for a Common Carrier Mediated Transport of Choline and Basic Drugs Through the Blood-brain Barrier

Overview
Specialty Pharmacology
Date 1990 Jun 1
PMID 2231266
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

The blood-brain barrier (BBB) transport system for choline and basic drugs was characterized by the in vivo carotid artery injection technique (Oldendorf, Brain Res., 24, 372-376, 1970) and in vitro uptake into isolated bovine brain capillaries (Pardridge et al., J. Neurochem., 44, 1178-1184, 1985). Basic drugs such as eperisone, thiamine and scopolamine significantly inhibited choline uptake by the BBB with the half inhibitory concentration, IC50 value of 1.45, 2.06, and 0.47 mM, respectively. On the contrary, the uptake of choline was not inhibited by amino acids (L-phenylalanine and L-arginine) and acidic drugs (nicotinic acid, salicylic acid and valproic acid). Choline was taken up by the isolated brain capillaries in concentration and temperature dependent manners. The uptake of choline by the isolated bovine brain capillaries was significantly inhibited by eperisone, scopolamine and thiamine in consistent with the in vivo results. Furthermore, eperisone inhibited competitively the uptake of choline with the inhibition constant, Ki value of 455 microM. According to these results it was suggested that in the BBB choline and basic drugs would share a common carrier-mediated transport system.

Citing Articles

Protective Effects of Choline against Inflammatory Cytokines and Characterization of Transport in Motor Neuron-like Cell Lines (NSC-34).

Latif S, Kang Y Pharmaceutics. 2022; 14(11).

PMID: 36365192 PMC: 9699384. DOI: 10.3390/pharmaceutics14112374.


Blood-Brain Barrier Solute Carrier Transporters and Motor Neuron Disease.

Latif S, Kang Y Pharmaceutics. 2022; 14(10).

PMID: 36297602 PMC: 9608738. DOI: 10.3390/pharmaceutics14102167.


Blood-brain barrier transport machineries and targeted therapy of brain diseases.

Barar J, Rafi M, Pourseif M, Omidi Y Bioimpacts. 2017; 6(4):225-248.

PMID: 28265539 PMC: 5326671. DOI: 10.15171/bi.2016.30.


Cation transport specificity at the blood-brain barrier.

Lockman P, McAfee J, Geldenhuys W, Allen D Neurochem Res. 2005; 29(12):2245-50.

PMID: 15672546 DOI: 10.1007/s11064-004-7032-4.


Differential effect of CDP-choline on brain cytosolic choline levels in younger and older subjects as measured by proton magnetic resonance spectroscopy.

Babb S, Appelmans K, Renshaw P, Wurtman R, Cohen B Psychopharmacology (Berl). 1996; 127(2):88-94.

PMID: 8888372 DOI: 10.1007/BF02805979.